In the BioHarmony Drug Report Database

"Preview" Icon

Sparfloxacin

Zagam (sparfloxacin) is a small molecule pharmaceutical. Sparfloxacin was first approved as Zagam on 1996-12-19. It is used to treat chlamydia infections, escherichia coli infections, haemophilus infections, klebsiella infections, and pneumonia amongst others in the USA.

 

Trade Name

 

Zagam
 

Common Name

 

sparfloxacin
 

ChEMBL ID

 

CHEMBL850
 

Indication

 

chlamydia infections, escherichia coli infections, haemophilus infections, klebsiella infections, pneumonia, proteus infections, salmonella infections, staphylococcal infections, streptococcal infections
 

Drug Class

 

Antibacterials (quinolone derivatives)

Image (chem structure or protein)

Sparfloxacin structure rendering